149 related articles for article (PubMed ID: 37298628)
1. IGFBP7 Fuels the Glycolytic Metabolism in B-Cell Precursor Acute Lymphoblastic Leukemia by Sustaining Activation of the IGF1R-Akt-GLUT1 Axis.
Artico LL; Ruas JS; Teixeira Júnior JR; Migita NA; Seguchi G; Shi X; Brandalise SR; Castilho RF; Yunes JA
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298628
[TBL] [Abstract][Full Text] [Related]
2. Physiologic IGFBP7 levels prolong IGF1R activation in acute lymphoblastic leukemia.
Artico LL; Laranjeira ABA; Campos LW; Corrêa JR; Zenatti PP; Carvalheira JBC; Brambilla SR; Nowill AE; Brandalise SR; Yunes JA
Blood Adv; 2021 Sep; 5(18):3633-3646. PubMed ID: 34438446
[TBL] [Abstract][Full Text] [Related]
3. IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias.
Gusscott S; Jenkins CE; Lam SH; Giambra V; Pollak M; Weng AP
PLoS One; 2016; 11(8):e0161158. PubMed ID: 27532210
[TBL] [Abstract][Full Text] [Related]
4. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.
Evdokimova V; Tognon CE; Benatar T; Yang W; Krutikov K; Pollak M; Sorensen PH; Seth A
Sci Signal; 2012 Dec; 5(255):ra92. PubMed ID: 23250396
[TBL] [Abstract][Full Text] [Related]
5. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody.
Chapuis N; Tamburini J; Cornillet-Lefebvre P; Gillot L; Bardet V; Willems L; Park S; Green AS; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
Haematologica; 2010 Mar; 95(3):415-23. PubMed ID: 20007139
[TBL] [Abstract][Full Text] [Related]
6. Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells.
Silva A; Gírio A; Cebola I; Santos CI; Antunes F; Barata JT
Leukemia; 2011 Jun; 25(6):960-7. PubMed ID: 21455214
[TBL] [Abstract][Full Text] [Related]
7. Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia.
Yamada H; Iijima K; Tomita O; Taguchi T; Miharu M; Kobayashi K; Okita H; Saito M; Shimizu T; Kiyokawa N
Int J Hematol; 2013 Jan; 97(1):73-82. PubMed ID: 23250859
[TBL] [Abstract][Full Text] [Related]
8. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
9. Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.
Gaben AM; Sabbah M; Redeuilh G; Bedin M; Mester J
BMC Cancer; 2012 Jul; 12():291. PubMed ID: 22799881
[TBL] [Abstract][Full Text] [Related]
10. IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival.
Verhagen HJ; de Leeuw DC; Roemer MG; Denkers F; Pouwels W; Rutten A; Celie PH; Ossenkoppele GJ; Schuurhuis GJ; Smit L
Cell Death Dis; 2014 Jun; 5(6):e1300. PubMed ID: 24967962
[TBL] [Abstract][Full Text] [Related]
11. Calcium deficiency-induced and TRP channel-regulated IGF1R-PI3K-Akt signaling regulates abnormal epithelial cell proliferation.
Dai W; Bai Y; Hebda L; Zhong X; Liu J; Kao J; Duan C
Cell Death Differ; 2014 Apr; 21(4):568-81. PubMed ID: 24336047
[TBL] [Abstract][Full Text] [Related]
12. Interaction between CD9 and PI3K‑p85 activates the PI3K/AKT signaling pathway in B‑lineage acute lymphoblastic leukemia.
Shi YF; Huang ZY; Huang YS; Dong RJ; Xing CY; Yu K; Leung KT; Feng JH
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036396
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
Hong SY; Yu FX; Luo Y; Hagen T
Cell Signal; 2016 May; 28(5):377-383. PubMed ID: 26826652
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 1 receptor promotes the growth and chemoresistance of pancreatic cancer.
Tian X; Hao K; Qin C; Xie K; Xie X; Yang Y
Dig Dis Sci; 2013 Sep; 58(9):2705-12. PubMed ID: 23589145
[TBL] [Abstract][Full Text] [Related]
15. HULC targets the IGF1R-PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance.
Zhou L; Li H; Sun T; Wen X; Niu C; Li M; Li W; Hoffman AR; Hu JF; Cui J
Cancer Lett; 2022 Nov; 548():215861. PubMed ID: 35981570
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J
Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693
[TBL] [Abstract][Full Text] [Related]
17. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia.
Grüninger PK; Uhl F; Herzog H; Gentile G; Andrade-Martinez M; Schmidt T; Han K; Morgens DW; Bassik MC; Cleary ML; Gorka O; Zeiser R; Groß O; Duque-Afonso J
Cancer Gene Ther; 2022 Nov; 29(11):1751-1760. PubMed ID: 35794338
[TBL] [Abstract][Full Text] [Related]
19. Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels.
Gomes AM; Soares MV; Ribeiro P; Caldas J; Póvoa V; Martins LR; Melão A; Serra-Caetano A; de Sousa AB; Lacerda JF; Barata JT
Haematologica; 2014 Jun; 99(6):1062-8. PubMed ID: 24561792
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.
Siska PJ; van der Windt GJ; Kishton RJ; Cohen S; Eisner W; MacIver NJ; Kater AP; Weinberg JB; Rathmell JC
J Immunol; 2016 Sep; 197(6):2532-40. PubMed ID: 27511728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]